Castration-resistant Prostate Cancer

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC

Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC

A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer

pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

AI Multimodal Model for Predicting CRPC Progression Risk

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway

Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)

Bipolar Androgen Therapy + Carboplatin in mCRPC

Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases.

A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC

Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer

GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy

A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer